GDF11 improves cardiac repair after myocardial infarction by reducing Macrophage infiltration and attenuating their inflammatory Properties.

Int Immunopharmacol

Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; State Key Laboratory of Transvascular Implantation Devices, China; Heart Regeneration and Repair Key Laboratory of Zhejiang province, China; Binjiang Institute of Zhejiang University, Hangzhou 310053, China. Electronic address:

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2024.113994DOI Listing

Publication Analysis

Top Keywords

gdf11 improves
4
improves cardiac
4
cardiac repair
4
repair myocardial
4
myocardial infarction
4
infarction reducing
4
reducing macrophage
4
macrophage infiltration
4
infiltration attenuating
4
attenuating inflammatory
4

Similar Publications

GDF11 improves cardiac repair after myocardial infarction by reducing Macrophage infiltration and attenuating their inflammatory Properties.

Int Immunopharmacol

January 2025

Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; State Key Laboratory of Transvascular Implantation Devices, China; Heart Regeneration and Repair Key Laboratory of Zhejiang province, China; Binjiang Institute of Zhejiang University, Hangzhou 310053, China. Electronic address:

View Article and Find Full Text PDF

Duplication of methyl-CpG-binding protein 2 (MECP2) gene causes MECP2 duplication syndrome (MDS). To normalize the duplicated MECP2 in MDS, we developed a high-fidelity Cas13Y (hfCas13Y) system capable of targeting the MECP2 (hfCas13Y-gMECP2) messenger RNA for degradation and reducing protein levels in the brain of humanized MECP2 transgenic mice. Moreover, the intracerebroventricular adeno-associated virus (AAV) delivery of hfCas13Y-gMECP2 in newborn or adult MDS mice restored dysregulated gene expression and improved behavior deficits.

View Article and Find Full Text PDF
Article Synopsis
  • Stem cell transplantation shows potential for heart regeneration after a heart attack, but success is limited due to the harsh conditions stem cells face in the damaged heart tissue; recent research is looking at ways to improve stem cell survival and function.* -
  • The study investigated the effects of GDF11 on reducing oxidative stress-related aging in endothelial progenitor cells (EPCs) that were exposed to oxidative stress, aiming to understand how to better support these stem cells post-transplantation.* -
  • Results indicated that GDF11 treatment reduced oxidative damage and senescence in EPCs, improved autophagy, and enhanced heart regeneration and blood vessel formation when EPCs were transplanted into heart tissue, suggesting a promising role for GDF11 in
View Article and Find Full Text PDF

Growth differentiation factor 11 (GDF11) belongs to the transforming growth factor beta superfamily and participates in various pathophysiological processes. Initially, GDF11 was suggested to act as a rejuvenator by improving age-related phenotypes of the heart, brain, and skeletal muscle in aged mice. Recent studies demonstrate that GDF11 also serves as an adverse risk factor for human frailty and diseases.

View Article and Find Full Text PDF

Background: The cognitive decline associated with type 2 diabetes (T2D) is often attributed to compromised hippocampal neurogenesis and exacerbated neural inflammation. This study investigates the therapeutic potential of growth differentiation factor 11 (GDF11) in reversing these neurodegenerative processes in diabetic mice.

Result: We utilized a murine model of T2D and examined the effects of GDF11 on learning, memory, neurogenesis, and neuroinflammatory markers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!